EyePoint (EYPT) Stock Price, Quote, News & History | Benzinga

EyePoint Inc (EYPT) Stock Price, Quote, News & History

EYPTNASDAQ

Trade with Public

Trade with Public

$14.75

1.279.42%

Last update: Aug 14, 7:39 PM

$15.08

1.6011.87%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$13.53

Close

$14.75

Volume / Avg.

2.51M / 1.42M

Day Range

$13.40 - $14.76

52 Wk Range

9.65 - 19.11

Market Cap

$1.30B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

21.99%

Days to Cover

12.35

Recent EyePoint Inc News

Paycom Software To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts changed outlook on top names: JP Morgan cut price target for Insulet, HC Wainwright slashed EyePoint's target, Goldman cut Sunrun's, B of A lowered Coupang's, BTIG cut Klaviyo's, Jefferies raised J&J Snack Foods', Raymond James raised Select Water Solutions', and Freedom Broker raised Danaos'.

Avi Kapoor

This Rambus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Wall Street analysts change outlook on top names. Check out analyst ratings page for upgrades, downgrades, and initiations. See how analysts view RMBS.

Avi Kapoor

Marriott Vacations To Rally Around 52%? Here Are 10 Top Analyst Forecasts For Thursday

Summary:Top Wall Street analysts changed outlook on top names. Analyst ratings page shows all changes. VEEV, GENI, DOW, BLLN, OKTA, VAC, WLK, EYPT had price target changes.

Avi Kapoor

The Year-End 2025 Biotech Rally And What It Means For 2026

Hillary Remy

EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study

EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-267.30M

Investing Cash Flow (TTM)

114.88M

Financing Cash Flow (TTM)

191.74M

Free Cash Flow (TTM)

-271.28M

Capital Expenditure (TTM)

-3.98M

Net Change in Cash (TTM)

39.32M

Analyst Trends and Forecast

3

Mar

1

May

1

Jun

3

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.11B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

394.17

PB Ratio (TTM)

6.99

Earnings Yield % (TTM)

-27.80%

Earnings Yield % (FWD)

-27.87%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.93

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$111.00K

Total Cash

$110.46M

Debt to Equity

0.12

Issuance of Debt (TTM)

-$111.00K

Repayment of Debt (TTM)

-$111.00K

Key Statistics

Open

$13.53

Close

$14.75

Volume / Avg.

2.51M / 1.42M

Day Range

$13.40 - $14.76

52 Wk Range

9.65 - 19.11

Market Cap

$1.30B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

21.99%

Days to Cover

12.35

About

Sector

Health Care

Industry

Pharmaceuticals

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy EyePoint (EYPT) stock?

A

You can purchase shares of EyePoint (NASDAQ:EYPT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are EyePoint (EYPT) competitors?

A

Other companies in EyePoint’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for EyePoint (EYPT) stock?

A

EyePoint has a consensus price target of $37.21.

Q

What is the current price for EyePoint (EYPT)?

A

The stock price for EyePoint (NASDAQ: EYPT) is $15.08 last updated August 14, 2026 at 7:39 PM EDT.

Q

Does EyePoint (EYPT) pay a dividend?

A

There are no upcoming dividends for EyePoint.

Q

When is EyePoint (NASDAQ:EYPT) reporting earnings?

A

EyePoint does not have any upcoming earnings scheduled.

Q

Is EyePoint (EYPT) going to split?

A

There is no upcoming split for EyePoint.

Q

What sector and industry does EyePoint (EYPT) operate in?

A

EyePoint is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.